Conivaptan hydrochloride is the hydrochloride salt of conivaptan. It is an antagonist for two of the three types of arginine vasopressin (AVP) receptors, V1a and V2, and is used to treat hyponatraemia (low blood sodium levels) caused by syndrome of inappropriate antidiuretic hormone (SIADH). Among its listed roles, it functions as a aquaretic and a vasopressin receptor antagonist. It includes a conivaptan. Its therapeutic use is listed as cardiovascular and hyponatremia agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Conivaptan HCl and Vaprisol. Its PubChem CID is 216322.
Conivaptan hydrochloride
| CAS No | 168626-94-6 |
|---|---|
| Molecular Formula | C32H27ClN4O2 |
| Molecular Weight | 535.0 g/mol |
| Synonyms | N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Conivaptan hydrochloride is the hydrochloride salt of conivaptan. It is an antagonist for two of the three types of arginine vasopressin (AVP) receptors, V1a and V2, and is used to treat hyponatraemia (low blood sodium levels) caused by syndrome of inappropriate antidiuretic hormone (SIADH).
The listed CAS number is 168626-94-6.
The listed molecular formula is C32H27ClN4O2.
The listed molecular weight is 535.0 g/mol.
N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide;hydrochloride.
The source lists Conivaptan HCl and Vaprisol.